AU2002366092A1 - 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides - Google Patents

1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides

Info

Publication number
AU2002366092A1
AU2002366092A1 AU2002366092A AU2002366092A AU2002366092A1 AU 2002366092 A1 AU2002366092 A1 AU 2002366092A1 AU 2002366092 A AU2002366092 A AU 2002366092A AU 2002366092 A AU2002366092 A AU 2002366092A AU 2002366092 A1 AU2002366092 A1 AU 2002366092A1
Authority
AU
Australia
Prior art keywords
pyrrolo
pyridine
carboxylic acid
acid amides
amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366092A
Other languages
English (en)
Inventor
Manuka Ghosh
George D. Maynard
Christopher J. O'donnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of AU2002366092A1 publication Critical patent/AU2002366092A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2002366092A 2001-11-19 2002-11-19 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides Abandoned AU2002366092A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33302701P 2001-11-19 2001-11-19
US60/333,027 2001-11-19
PCT/US2002/037157 WO2003044018A1 (en) 2001-11-19 2002-11-19 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides

Publications (1)

Publication Number Publication Date
AU2002366092A1 true AU2002366092A1 (en) 2003-06-10

Family

ID=23300941

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366092A Abandoned AU2002366092A1 (en) 2001-11-19 2002-11-19 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides

Country Status (7)

Country Link
EP (1) EP1453831A1 (enExample)
JP (1) JP2005516901A (enExample)
AU (1) AU2002366092A1 (enExample)
BR (1) BR0214301A (enExample)
CA (1) CA2467542A1 (enExample)
MX (1) MXPA04004711A (enExample)
WO (1) WO2003044018A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2865208B1 (fr) * 2004-01-16 2009-01-16 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
FR2890072A1 (fr) * 2005-09-01 2007-03-02 Fournier S A Sa Lab Nouveaux composesde pyrrolopyridine
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
WO2014196793A1 (en) 2013-06-05 2014-12-11 C&C Research Laboratories Heterocyclic derivatives and use thereof
GB201317363D0 (en) 2013-10-01 2013-11-13 Eisai Ltd Novel compounds
CN116102549B (zh) * 2021-11-09 2025-02-11 暨南大学 5-醛基杂环酰胺类化合物及其应用
WO2023082044A1 (zh) * 2021-11-09 2023-05-19 暨南大学 5-醛基杂环酰胺类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
EP1453831A1 (en) 2004-09-08
JP2005516901A (ja) 2005-06-09
WO2003044018A1 (en) 2003-05-30
MXPA04004711A (es) 2005-08-16
CA2467542A1 (en) 2003-05-30
BR0214301A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
IL160707A0 (en) 1, 8-naphthyridine derivatives as antidiabetics
AU2002358718A1 (en) 2-heteroarylcarboxylic acid amides
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2002229976A1 (en) Imidazopyridines
PL373424A1 (en) Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2002352142A1 (en) Pyrazolopyridine derivatives
AU2002216028A1 (en) Novel carbamate-substituted pyrazolopyridine derivatives
AU2002328596A1 (en) Diamine derivatives
AU2002367323A1 (en) Benzothieno (3,2-
AU2003219661A1 (en) Thieno (3, 2-b) pyridones as antiviral compounds
AU2003300883A1 (en) Substituted 1-benzoyl-3-cyano-pyrrolo(1,2-a)quinolines
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2003293886A1 (en) (1,7)naphthyridines as pde4 inhibitors
AU2003205130A1 (en) Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
AU2002314235A1 (en) Block copolymer preparation method
AU2002233664A1 (en) Naphthyridine derivative
AU2003250090A1 (en) 2,4-dihydroxybenzoic acid derivatives
AU2002323523A1 (en) 4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
AU2002331567A1 (en) 4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
AU2002323066A1 (en) Therapeutic 1h-pyrido(4,3-b)indoles
HK1065035A (en) 4-thioxo-4, 7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
AU2001285801A1 (en) 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivates
AU2002327568A1 (en) 4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carboxamides as ant iviral agents
AU2002317000A1 (en) Morpholine-bridged pyrazolopyridine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase